cholinergic receptors definetion and classifcation to 1-nicotinic and 2-muscarinic ...and their subtybes ..... then the sites and the mechanism ... and last the drugs effect
This presentation was given by me during my M.pharm.
It contains description, classification, mechanism of actions and therapeutic uses of Neuromuscular blockers.
Adrenoceptors are membrane bound receptors located throughout the body on neuronal and non-neuronal tissues where they mediate a diverse range of responses to the endogenous catecholamines- noradrenaline and adrenaline.
They are G protein coupled receptors.
Binding of catecholamine to the receptor is responsible for fight or flight response.
Acetylcholine -
Acetylcholine is an organic chemical that functions in the brain and body of many types of animals as a neurotransmitter—a chemical message released by nerve cells to send signals to other cells, such as neurons, muscle cells and gland cells.
This presentation was given by me during my M.pharm.
It contains description, classification, mechanism of actions and therapeutic uses of Neuromuscular blockers.
Adrenoceptors are membrane bound receptors located throughout the body on neuronal and non-neuronal tissues where they mediate a diverse range of responses to the endogenous catecholamines- noradrenaline and adrenaline.
They are G protein coupled receptors.
Binding of catecholamine to the receptor is responsible for fight or flight response.
Acetylcholine -
Acetylcholine is an organic chemical that functions in the brain and body of many types of animals as a neurotransmitter—a chemical message released by nerve cells to send signals to other cells, such as neurons, muscle cells and gland cells.
In general Tobacco is always considered to be useful for its nicotine content. but there are far more important uses of it, such as in medicinal fields.
Pulse Publish a post CYP2A6 Genes Polymorphism Roles in Nicotine Depende...Yawo Akrodou
Functionally genes provide the information that governs the basic biologic and physiological activities of cells conditioning our behavior in relationship with our environment changes. CYP2A6 variants variably inhibit and reduce nicotine dependence and play a significant role in nicotine uptake, distribution, and clearance, implying their clinical potential. Also, CYP2A6 variants have been linked to smoking behavior, nicotine-dependence development, and treatment in epidemiological quantitative and human laboratory studies. It appears in this current study that CYP2A6 variants’ enzymatic activities are correlated to variation in smoking behaviors and are implicated in nicotine treatments as they are capable of metabolizing nicotine, and medication use in nicotine addiction treatment.
Understanding And Addressing Nicotine Addiction: A Science-Based Approach to ...Center on Addiction
Nicotine is a highly addictive substance that not only perpetuates tobacco use, the leading cause of preventable morbidity and mortality in the United States, but also has its own adverse effects. Nicotine addiction is a chronic and relapsing disease and the prevalence of nicotine addiction is higher than that of alcohol and other drug addiction. The use of nicotine-containing products not only is associated with developing nicotine addiction, but also with using and becoming addicted to alcohol and other drugs.
Despite the decline in recent years in the use of cigarettes, the use of alternative, non-cigarette nicotine products has been rising dramatically. While the overall harm of these products appears to be considerably lower than the harms associated with cigarette use, all nicotine-containing products carry the risk of addiction and other adverse health effects and, therefore, are a threat to the public health.
Ways for you to detoxify from nicotine, how long nicotine stays in your system and how to detect nicotine in the body.
http://howlongdoesnicotinestayinyoursystem.net
Neurohumoral Transmission of Acetylcholine.pptxShraddhaRaut43
This presentation will provide you an insight into the Neurohumoral Transmission of Acetylcholine in Autonomic Nervous System. Acetylcholine is a chemical messenger and principle neurotransmitter of Parasympathetic Nervous system. It will help you to cover this topic from syllabus and from exam point of view. Check out the ppt to boost your knowledge on this topic as it gives you a detailed knowledge of acetylcholine transmission.
A substance that is released at a synapse by a neuron and that effects another cell, either a neuron or an effectors organ, in a specialized manner , called neurotransmitter.
The parasympathetic division typically acts in opposition to the sympathetic autonomic nervous system through negative feedback control.
This action is a complementary response, causing a balance of sympathetic and parasympathetic responses.
Overall, the parasympathetic outflow results in the conservation and restoration of energy, reduction in heart rate and blood pressure, facilitation of digestion and absorption of nutrients, and excretion of waste products.
These are drugs that produce actions similar to that of Acetylcholine hence known as parasympathomimetics.
They act either by directly interacting with cholinergic receptors or by increasing the availability of Acetylcholine at these sites.
Autonomic Nervous Sytem and neurohumoral transmission-Dr.Jibachha Sah,M.V.Sc,...Dr. Jibachha Sah
Dr. Jibachha Sah,M.V.Sc( Veterinary pharmacology, TU,Nepal),posted lecturer notes on AUTONOMIC AND SYSTEMIC PHARMACOLOGY for B.V.Sc & A.H. 6 th semester veterinary students of College of veterinary science,Nepal Polytechnique Institute, Bharatpur, Bhojard, Chitwan, Nepal.I hope this lecture notes may be beneficial for other Nepalese veterinary students. Please send your comment and suggestion .Email:jibachhashah@gmail.com,moble,00977-9845024121
Cholinergic drugs inhibit, enhance, or mimic the action of the neurotransmitter acetylcholine, the primary transmitter of nerve impulses within the parasympathetic nervous system
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
2. CHOLINERGIC RECEPTORS
DEFINITION
: chemical sites in effector cells or at
synapses through which
acetylcholine exerts its action,
i.e: cholinergic receptors respond to
Acetyle Cholin in neuro-synapse .
3.
4. THE HUMAN BRAIN HAS A HUGE NUMBER
OF SYNAPSES. EACH OF THE 10^11 (ONE
HUNDRED BILLION) NEURONS HAS ON
AVERAGE 7,000 SYNAPTIC CONNECTIONS
TO OTHER NEURONS.
8. N1 OR N RECEPTORS:
THESE RECEPTORS ARE LOCATED AT THE
NEUROMUSCULAR JUNCTION,
-ACETYLCHOLINE RECEPTORS OF THE NM
SUBTYPE ARE THE ONLY ACETYLCHOLINE
RECEPTORS THAT CAN BE FOUND AT THE
NEUROMUSCULAR JUNCTION.
9. N2 OR NN RECEPTORS:
AS MENTIONED BEFORE, NICOTINIC
RECEPTORS PLAY A KEY ROLE IN THE
TRANSMISSION OF CHOLINERGIC SIGNALS
IN THE AUTONOMIC NERVOUS SYSTEMS.
-NICOTINIC RECEPTORS OF THE NN
SUBTYPE CAN BE FOUND BOTH AT
CHOLINERGIC AND ADRENERGIC
GANGLIA, BUT NOT AT THE TARGET TISSUES
(E.G, HEART, BLADDER, ETC). THESE
RECEPTORS ARE ALSO PRESENT IN THE CNS
AND ADRENAL MEDULLA.
10.
11. M1, M4 and M5 receptors:
CNS. These receptors are involved in
complex CNS responses such as memory,
arousal, attention and analgesia.
M1 receptors are also found at gastric
parietal cells and autonomic ganglia.
12. M2 receptors:
heart. Activation of M2 receptors
lowers conduction velocity at
sinoatrial and atrioventricular
nodes, thus lowering
heart rate.
13. M3 receptors:
smooth muscle. Activation of M3
receptors at the smooth muscle level
produces responses on a variety of
organs that include: bronchial tissue,
bladder, exocrine glands, among others.
14. CHOLINERGIC NEURONS
Cholinergic neurons: are those which release ac.ch at
their endings
Types of cholinergic neurons:
1-Central cholinergic neurons: arise from CNS including
all pregang neurons and somatic nerves
2-Peripheral cholinergic neurons: arise from autonomic
ganglia including all parasympath and sympathetic
cholinergic postganglionic nerves
15. MECHANISM :-
•It binds with cholinergic receptors in effectors
organs.
•Change of permeability of cell membrane to
various ions
•It either increases permeability to Na or Ca
ions or to K and Cl.
20. i.e. : the main idea is to block the sites of cholinergic
receptors in the synapse in 2 ways >>>
1-to fill the receptors sites with agonists of muscarinic or
nicotinic .
2-use anticholinesterase to stop cholinesterase work .. and
the sites will still filled with ACH .